Despite the past decline, the stock is still selling for more than most others in its industry. Looking ahead, other than the push or pull of the broad market, we do not see anything in the company's numbers that may help reverse the decline experienced over the past 12 months. The share price of IGI LABORATORIES INC has not done very well: it is down 23.16% and has underperformed the S&P 500, in part reflecting the company's sharply declining earnings per share when compared to the year-earlier quarter.Despite the mixed results of the gross profit margin, IG's net profit margin of 105.43% significantly outperformed against the industry. Regardless of IG's high profit margin, it has managed to decrease from the same period last year. 42.88% is the gross profit margin for IGI LABORATORIES INC which we consider to be strong.When compared to other companies in the Pharmaceuticals industry and the overall market, IGI LABORATORIES INC's return on equity exceeds that of the industry average and significantly exceeds that of the S&P 500. This is a signal of significant strength within the corporation. The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior.This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share. Since the same quarter one year prior, revenues rose by 37.2%. The revenue growth greatly exceeded the industry average of 6.9%.Highlights from the ratings report include: However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, weak operating cash flow and generally higher debt management risk. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and compelling growth in net income. Click here to see his holdings for 14-days FREE. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.Д®XCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). 'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. IG is trading at a new low 6.03% below yesterday's close.IG is trading at 9.25 times the normal volume for the stock at this time of day.IG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $3.8 million.In addition to specific proprietary factors, Trade-Ideas identified IGI Laboratories as such a stock due to the following factors: IG International Limited receives services from other members of the IG Group including IG Markets Limited.) as a weak on high relative volume candidate. IG International Limited is part of the IG Group and its ultimate parent company is IG Group Holdings Plc. The information on this site is not directed at residents of the United States and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. The information in this site does not contain (and should not be construed as containing) investment advice or an investment recommendation, or an offer of or solicitation for transaction in any financial instrument.

IG International Limited is licensed to conduct investment business and digital asset business by the Bermuda Monetary Authority. You should consider whether you understand how this product works, and whether you can afford to take the high risk of losing your money.Д¬FD Accounts provided by IG International Limited. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The risks of loss from investing in CFDs can be substantial and the value of your investments may fluctuate.

Igi stock